Jul 15, 2013 8:05am EDT Immunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-Survivac
Jun 03, 2013 8:05am EDT Immunovaccine Shows Pronounced and Persistent T Cell Immune Responses in DPX-Survivac Cancer Vaccine Study Presented at American Society of Clinical Oncology (ASCO) Meeting
May 30, 2013 8:05am EDT New European Phase II Trial to Test Immunovaccine's DPX-Survivac in Brain Cancer Patients
May 29, 2013 8:05am EDT Immunovaccine to Present Clinical Data on its DPX-Survivac Cancer Vaccine at the 2013 ASCO Annual Meeting
May 16, 2013 5:05pm EDT Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013
Jan 30, 2013 8:05am EST Immunovaccine Signs Agreement for Phase I/II Clinical Trial of DPX-0907 in Breast and Ovarian Cancer Patients
Jan 07, 2013 8:05am EST Immunovaccine's DPX-Survivac Produces Sustained, Dose Related Immune Responses in Phase I Ovarian Cancer Study
Jan 03, 2013 8:05am EST Immunovaccine Reports Positive Results from Ongoing Study of DepoVax(TM)-Based Anthrax Vaccines
Nov 16, 2012 8:05am EST Immunovaccine Announces Financial Results for the Quarter Ended September 30, 2012
Oct 02, 2012 12:39pm EDT Immunovaccine Inc. to Webcast, Live, at RetailInvestorConferences.com on October 4th
